Gilead Sciences Inc (GILD)
106.74
-0.34
(-0.32%)
USD |
NASDAQ |
Mar 24, 16:00
106.41
-0.33
(-0.31%)
After-Hours: 20:00
Gilead Sciences Shareholders Equity (Quarterly): 19.33B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 5.877B |
| Johnson & Johnson | 71.49B |
| Eli Lilly and Co | 14.19B |
| Vertex Pharmaceuticals Inc | 16.41B |
| Moderna Inc | 10.90B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.00B |
| Total Liabilities (Quarterly) | 39.75B |
| Debt to Equity Ratio | 1.382 |
| Current Ratio | 1.597 |
| Net Debt Paydown Yield | -0.30% |